Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Mucosal Aphthous stomatitis (2003): Yoshida T+, J Rheumatol 30(9), 2082 Gingivitis (>10%) Glossitis (>10%) Mucositis (2005): Mazokopakis EE+, Phytomedicine 12(1-2), 25 (2005): Tonanont M+, J Med Assoc Thai 88(10), 1349 (6%) (2000): Alfaro J+, Rev Med Chil (Spanish) 128, 315 Oral mucositis (1997): Plevova P+, J Natl Cancer Inst 89, 326 (1996): Moe PJ, Pediatr Hematol Oncol 13, 313 (1996): Rask C+, Pediatr Hematol Oncol 13, 359 (1996): Zackheim HS+, JAmAcadDermatol34, 626 Oral ulceration (2005): Deeming GM+, Br Dent J 2005 Jan 22;198(2), 83 (2003): Prescrire Int 12(64), 59 (2001): Litt JZ, Beachwood, OH (severe) (personal case) (observation) (2001): Werth V, Dermatology Times 15 (2000): Madinier I+, Ann Med Interne (Paris) (French) 151, 248 (1986): Barrett AP, JPeriodontol57, 318 Stomatitis (3–10%) (1998): Roenigk HH+, JAmAcadDermatol38, 478 (ulcerative) (1998): Zieglschmid ME+, JAmAcadDermatol38, 130 (1997): Kasteler JS+, JAmAcadDermatol36, 67 (passim) (1996): Vonderheid EC+, JAmAcadDermatol34, 470 (1995): Zieglschmid-Adams ME+, JAmAcadDermatol32, 754 (1994): Montecucco C+, Arthritis Rheum 37, 777 Hair Hair – alopecia (1–6%) (2006): Weisman MH+, Arthritis Rheum 54(2), 607 (2000): Emery P+, Rheumatology (Oxford) 39, 655 (1998): Roenigk HH+, JAmAcadDermatol38, 478 (1998): Zieglschmid ME+, JAmAcadDermatol38, 130 (1997): Kasteler JS+, JAmAcadDermatol36, 67 (passim) (1996): Zackheim HS+, JAmAcadDermatol34, 626 (1995): Zieglschmid-Adams ME+, JAmAcadDermatol32, 754 (1989): Fehlauer CS+, J Rheumatol 16, 307 (1988): Weinblatt ME+, Arthritis Rheum 31 (Suppl), s115 (1982): Bachman DM, Arthritis Rheum 25, s65 (1982): Bertino JR, Med Pediatr Oncol 10, 401 Hair – pigmented bands (1983): Wheeland RG+, Cancer 51, 1356 Nails Nails – discoloration Nails – onycholysis (1987): Chang JC, Arch Dermatol 123, 990 Nails – paronychia (1983): Wantzin GL+, Arch Dermatol 119, 623 Nails – pigmentation (1998): Malka N+, Dermatology 197(3), 276 (yellow) (1981): Nixon DW+, Cutis 27, 181 Eyes Optic neuropathy (2005): Clare G+, J Neuroophthalmol 25(2), 109 (2002): Balachandran C+, Clin Experiment Ophthalmol 30(6), 440 Scotoma (2006): Sbeity ZH+, JMedLiban54(3), 164 Visual disturbances (2004): Johansson B, Acta Ophthalmol Scand 2004 Oct;82(5), 625 Other Anaphylactoid reactions/Anaphylaxis (1–10%) (2006): Houtman PM+, J Clin Rheumatol 12(6), 321 (with etanercept) METHOTREXATE 357 (2003): Prescrire Int 12(64), 59 (2003): MacGinnitie AJ+, Pediatr Allergy Immunol 14(5), 409 (1996): Alkins SA+, Cancer 77, 2123 (1995): Lobelle C+, Pediatr Hematol Oncol 12, 213 Candidiasis Cough (2006): Weisman MH+, Arthritis Rheum 54(2), 607 Death (2006): Kelly H+, Obstet Gynecol 107(2), 439 (2005): Kinder AJ+, Rheumatology (Oxford) 44(1), 61 Gynecomastia (2006): Pandhi D+, Clin Exp Dermatol 31(1), 138 (2004): Schmutz JL+, Ann Dermatol Venereol 131(11), 1024 (1995): Finger DR+, J Rheumatol 22, 796 (1995): Thomas E+, J Rheumatol 22, 2189 (1983): Del Paine DW+, Arthritis Rheum 26, 691 Hepatotoxicity (2006): Berends MA+, Aliment Pharmacol Ther 24(5), 805 (2006): Boey O+, Acta Clin Belg 61(4), 166 (2006): Tilling L+, Clin Drug Investig 26(2), 55 (2005): Nieminen U+, Duodecim - Duodecim 121(24), 2680 (2005): Tonanont M+, J Med Assoc Thai 88(10), 1349 (6%) (1998): Hakim NS+, Int Surg 83(3), 224 (1997): Cuellar ML+, Rheum Dis Clin North Am 23(4), 797 Hypersensitivity (2003): Prescrire Int 12(64), 59 Inappropriate secretion of antidiuretic hormone (SIADH) (1988): Frahm H+, Z Gesamte Inn Med 43(15), 411 Myalgia/Myositis/Myopathy/Myotoxicity Nephrotoxicity (2006): Widemann BC+, Oncologist 11(6), 694 (2004): Widemann BC+, Cancer 100(10), 2222 (%) (2003): Kinoshita A+, Cancer Chemother Pharmacol 51(3), 256 (2003): Miyazaki J+, Nippon Rinsho 61(6), 973 (2002): Saland JM+, Pediatr Nephrol 17(10), 825 (2002): Sauer M+, Pediatr Hematol Oncol 19(2), 135 (2001): Kintzel PE, Drug Saf 24(1), 19 (2000): Abrey LE+, J Clin Oncol 18(17), 3144 (1999): Krackhardt A+, Leuk Lymphoma 35(5–6), 631 (1998): Kepka L+, Leuk Lymphoma 29(1–2), 205 (1998): Koch Nogueira PC+, Pediatr Nephrol 12(7), 572 (1997): Tesar V+, Cas Lek Cesk 136(7), 205 (1997): Widemann BC+, J Clin Oncol 15(5), 2125 Neurotoxicity (2006): Haykin ME+, J Neurooncol 76(2), 153 (2006): Nakajima D+, No To Hattatsu 38(3), 195 Panniculitis (2002): Nezondet-Chetaille AL+, Joint Bone Spine 69(3), 324 Peyronie’s disease (1992): Phelan MJI, Br J Rheumatol 31, 425 Porphyria cutanea tarda (1983): Malina L+, ZHautkr(German) 58, 241 Pseudolymphoma (1997): Flipo RM+, J Rheumatol 24, 809 (1995): Delaporte E+, Ann Dermatol Venereol (French) 122, 521 (20 cases) (1994): Zimmer-Galler I+, Mayo Clin Proc 69, 258 (1993): Kamel OW+, NEnglJMed328, 1317 (1993): Kerl H+, Dermatology in General Medicine McGraw-Hill, New York (1993): Shiroky JB+, NEnglJMed329(22), 1657 (1993): Taillan B+, Rev Rhum Ed Fr 60(3), 248 (1992): Kingsmore SF+, J Rheumatol 19(9), 1462 (1991): Ellman MH+, J Rheumatol 18(11), 1741 (1991): Shiroky JB+, J Rheumatol 18(8), 1172 Tendinopathy/Tendon rupture (2001): Toverud EL+, Med Pediatr Oncol 37(2), 156 (Achilles; repeated)
358 METHOXSALEN METHOXSALEN Trade names: 8-MOP (Valeant); Geroxalen; Meladinine; Oxsoralen (Valeant); Oxsoralon; Puvasoralen; Ultra-MOP Indications: Psoriasis, vitiligo Category: Psoralen; Repigmenting agent Half-life: 1.1 hours Clinically important, potentially hazardous interactions with: caffeine, chloroquine, cyclosporine, fluoroquinolones, phenothiazines, sulfonamides Reactions Skin Acne Acute generalized exanthematous pustulosis (AGEP) (2002): Morant C+, Ann Dermatol Venereol 129(2), 234 Basal cell carcinoma (1996): Stern RS+, JPediatr129, 915 (1995): Gritiyarangsan P+, Photodermatol Photoimmunol Photomed 11, 174 Bowen’s disease Bullous dermatitis (with UVA) (1982): Stüttgen G, Int J Dermatol 21, 198 Bullous pemphigoid (1996): Perl S+, Dermatology 193, 245 Burning (1–10%) (1996): Geary P, Burns 22, 636 (1991): Boucaud C+, Presse Med (French) 20, 1945 (1982): Stüttgen G, Int J Dermatol 21, 198 (passim) (1–10%) Carcinoma (1995): Halder RM+, Arch Dermatol 131, 734 (1984): Halprin KM+, Natl Cancer Inst Monogr 66, 185 Dermatitis (1994): Korffmacher H+, Contact Dermatitis 30, 283 (1991): Takashima A+, Br J Dermatol 124, 37 (1980): Weissmann I+, Br J Dermatol 102, 113 Eczema Edema (1–10%) Ephelides (1–10%) (1995): Gritiyarangsan P+, Photodermatol Photoimmunol Photomed 11, 174 (1995): Pierard GE+, Dermatology 190, 338 (1984): Kietzmann E+, Dermatologica 168, 306 (1983): Kanerva L+, Dermatologica 166, 281 (1983): Kietzmann H+, Ann Dermatol Venereol (French) 110, 63 Erythema (1–10%) Exanthems (2001): Ravenscroft J+, JAmAcadDermatol45, S2118–9 (1986): Gisslen P+, Photodermatol 3, 308 Exfoliative dermatitis Granuloma annulare Herpes simplex (1982): Stüttgen G, Int J Dermatol 21, 198 Herpes zoster (1982): Stüttgen G, Int J Dermatol 21, 198 Hypomelanosis (1–10%) Lichen planus (2003): Nanda S+, JDermatol30(2), 151 Lichen planus pemphigoides (2000): Kuramoto N+, Br J Dermatol 142(3), 509 Lupus erythematosus (1985): Bruze M+, Acta Derm Venereol (Stockh) 65, 31 Miliaria Pemphigus Photosensitivity (2001): Tanew A+, JAmAcadDermatol44, 638 (1998): Clark SM+, Contact Dermatitis 38, 289 (1992): Jeanmougin M+, Ann Dermatol Venereol (French) 119, 277 (1991): Boucaud C+, Presse Med (French) 20, 1945 (1991): Takashima A+, Br J Dermatol 124, 37 (1990): Cox NH+, Clin Exp Dermatol 15, 75 (1989): Cox NH+, Photodermatol 6, 96 Phototoxicity (1997): Morison WL+, JAmAcadDermatol36, 183 (1993): Calzavara-Pinton PG+, JAmAcadDermatol28, 657 (1989): Morison WL, Arch Dermatol 125, 433 (topical) (1985): Berakha GJ+, Ann Plast Surg 14, 458 (1984): Meffert H+, Photodermatol 1, 191 Pigmentation (1989): Weiss E+, Int J Dermatol 28, 188 (1987): Bruce DR+, JAmAcadDermatol16, 1087 (1986): MacDonald KJS+, Br J Dermatol 114, 395 Porokeratosis (actinic) (1988): Beiteke U+, Photodermatol 5, 274 (1985): Hazen PG+, JAmAcadDermatol12, 1077 (1980): Reymond JL, Acta Derm Venereol (Stockh) 60, 539 Prurigo (1982): Stüttgen G, Int J Dermatol 21, 198 (passim) Pruritus (>10%) (1982): Stüttgen G, Int J Dermatol 21, 198 (passim) Purpura (1981): Barriere H+, Nouv Presse Med (French) 10, 337 Rash (sic) (1–10%) Scleroderma Seborrheic dermatitis (1983): Tegner E, Acta Derm Venereol (Stockh) Suppl 107, 5 Squamous cell carcinoma (1998): Stern RS+, Arch Dermatol 134, 1582 (with UVA) (1986): Kahn JR+, Clin Exp Dermatol 11, 398 Urticaria (1994): Bech-Thomsen N+, JAmAcadDermatol31, 1063 Vasculitis (1981): Barriere H+, Presse Med (French) 10, 37 Verrucae (1982): Stüttgen G, Int J Dermatol 21, 198 Vitiligo (1983): Tegner E, Acta Derm Venereol (Stockh) Suppl 107, 5 Xerosis Mucosal Cheilitis (1–10%) Hair Hair – hypertrichosis (1983): Rampen FHJ, Br J Dermatol 109, 657 Nails Nails – photo-onycholysis (1990): Baran R+, Ann Dermatol Venereol (French) 117, 367 (1984): Balato N+, Photodermatol 1, 202 Nails – pigmentation (1990): Trattner A+, Int J Dermatol 29, 310 (1989): Weiss E+, Int J Dermatol 28, 188 (1986): MacDonald KJS+, Br J Dermatol 114, 395 (1982): Naik RPC+, Int J Dermatol 21, 275 Other Anaphylactoid reactions/Anaphylaxis (2003): Park JY+, Photodermatol Photoimmunol Photomed 19(1), 37 (2001): Legat FJ+, Br J Dermatol 145(5), 821 Lymphoproliferative disease (1989): Aschinoff R+, JAmAcadDermatol21, 1134 Pain
- Page 382 and 383: ISOSORBIDE Trade name: Ismotic Indi
- Page 384 and 385: Nails Nails - brittle (2001): Önde
- Page 386 and 387: Serum sickness (1998): Park H+, Ann
- Page 388 and 389: (2001): Burstal R+, Anaesth Intensi
- Page 390 and 391: Pruritus (1-10%) Psoriasis (1992):
- Page 392 and 393: LAMIVUDINE Synonym: 3TC Trade names
- Page 394 and 395: (2006): Fix OK+, Clin Gastroenterol
- Page 396 and 397: Eyelashes - ptosis (2005): Casson R
- Page 398 and 399: LETROZOLE Trade name: Femara (Novar
- Page 400 and 401: Other Abdominal pain (2003): Cramer
- Page 402 and 403: Photosensitivity (
- Page 404 and 405: (2002): Kalin JR+, JForensicSci47(5
- Page 406 and 407: (2002): Serratrice J+, Am J Ophthal
- Page 408 and 409: (1981): Hess EV, Arthritis Rheum 24
- Page 410 and 411: Purpura (
- Page 412 and 413: Reactions Skin Angioedema (
- Page 414 and 415: Other Abdominal pain (7%) Cough (1%
- Page 416 and 417: Reactions Skin Acne (1998): Wollina
- Page 418 and 419: (1983): Nusbaum BP+, Arch Dermatol
- Page 420 and 421: (1997): O’Reilly FM+, American Ac
- Page 422 and 423: MEMANTINE Trade names: Akatinol; Ax
- Page 424 and 425: MERCAPTOPURINE Synonyms: 6-mercapto
- Page 426 and 427: (1998): Leal G, Fortaleza, Brazil (
- Page 428 and 429: (2002): Caplehorn JR+, Aust N Z J P
- Page 430 and 431: (1995): Vogt T+, Br J Dermatol 133,
- Page 434 and 435: (1987): Norris PG+, Clin Exp Dermat
- Page 436 and 437: (1998): Corazza M+, Contact Dermati
- Page 438 and 439: METOCLOPRAMIDE Trade names: Apo-Met
- Page 440 and 441: Oral ulceration Stomatitis (1987):
- Page 442 and 443: Reactions Skin Erythema multiforme
- Page 444 and 445: (1996): Carrington PR, Little Rock,
- Page 446 and 447: (2003): Abe M+, Intern Med 42(1), 4
- Page 448 and 449: Other Abdominal pain (2006): Preutt
- Page 450 and 451: Erythema multiforme Exanthems (9-16
- Page 452 and 453: Other Anaphylactoid reactions/Anaph
- Page 454 and 455: MUPIROCIN* Trade names: Bactoderm;
- Page 456 and 457: Mucosal Gingivitis (
- Page 458 and 459: (1981): Wolf A, ZHautkr(German) 56,
- Page 460 and 461: (1984): Stern RS+, JAMA 252, 1433 V
- Page 462 and 463: Hair Hair - alopecia (
- Page 464 and 465: NEVIRAPINE Trade name: Viramune (Bo
- Page 466 and 467: (1982): Grunwald Z, Drug Intell Cli
- Page 468 and 469: Urticaria (
- Page 470 and 471: (2000): Rodrigues de Oliveira J+, G
- Page 472 and 473: (2007): Koulaouzidis A+, Ann Hepato
- Page 474 and 475: Vulvovaginal candidiasis (2002): Me
- Page 476 and 477: Mucosal Oral mucosal eruption (1987
- Page 478 and 479: Mucosal Tongue edema Other Anaphyla
- Page 480 and 481: Chills (5-10%) Hypersensitivity (
Mucosal<br />
Aphthous stomatitis<br />
(2003): Yoshida T+, J Rheumatol 30(9), 2082<br />
Gingivitis (>10%)<br />
Glossitis (>10%)<br />
Mucositis<br />
(2005): Mazokopakis EE+, Phytomedicine 12(1-2), 25<br />
(2005): Tonanont M+, J Med Assoc Thai 88(10), 1349 (6%)<br />
(2000): Alfaro J+, Rev Med Chil (Spanish) 128, 315<br />
Oral mucositis<br />
(1997): Plevova P+, J Natl Cancer Inst 89, 326<br />
(1996): Moe PJ, Pediatr Hematol Oncol 13, 313<br />
(1996): Rask C+, Pediatr Hematol Oncol 13, 359<br />
(1996): Zackheim HS+, JAmAcadDermatol34, 626<br />
Oral ulceration<br />
(2005): Deeming GM+, Br Dent J 2005 Jan 22;198(2), 83<br />
(2003): Prescrire Int 12(64), 59<br />
(2001): Litt JZ, Beachwood, OH (severe) (personal case)<br />
(observation)<br />
(2001): Werth V, Dermatology Times 15<br />
(2000): Madinier I+, Ann Med Interne (Paris) (French) 151, 248<br />
(1986): Barrett AP, JPeriodontol57, 318<br />
Stomatitis (3–10%)<br />
(1998): Roenigk HH+, JAmAcadDermatol38, 478 (ulcerative)<br />
(1998): Zieglschmid ME+, JAmAcadDermatol38, 130<br />
(1997): Kasteler JS+, JAmAcadDermatol36, 67 (passim)<br />
(1996): Vonderheid EC+, JAmAcadDermatol34, 470<br />
(1995): Zieglschmid-Adams ME+, JAmAcadDermatol32, 754<br />
(1994): Montecucco C+, Arthritis Rheum 37, 777<br />
Hair<br />
Hair – alopecia (1–6%)<br />
(2006): Weisman MH+, Arthritis Rheum 54(2), 607<br />
(2000): Emery P+, Rheumatology (Oxford) 39, 655<br />
(1998): Roenigk HH+, JAmAcadDermatol38, 478<br />
(1998): Zieglschmid ME+, JAmAcadDermatol38, 130<br />
(1997): Kasteler JS+, JAmAcadDermatol36, 67 (passim)<br />
(1996): Zackheim HS+, JAmAcadDermatol34, 626<br />
(1995): Zieglschmid-Adams ME+, JAmAcadDermatol32, 754<br />
(1989): Fehlauer CS+, J Rheumatol 16, 307<br />
(1988): Weinblatt ME+, Arthritis Rheum 31 (Suppl), s115<br />
(1982): Bachman DM, Arthritis Rheum 25, s65<br />
(1982): Bertino JR, Med Pediatr Oncol 10, 401<br />
Hair – pigmented b<strong>and</strong>s<br />
(1983): Wheel<strong>and</strong> RG+, Cancer 51, 1356<br />
Nails<br />
Nails – discoloration<br />
Nails – onycholysis<br />
(1987): Chang JC, Arch Dermatol 123, 990<br />
Nails – paronychia<br />
(1983): Wantzin GL+, Arch Dermatol 119, 623<br />
Nails – pigmentation<br />
(1998): Malka N+, Dermatology 197(3), 276 (yellow)<br />
(1981): Nixon DW+, Cutis 27, 181<br />
Eyes<br />
Optic neuropathy<br />
(2005): Clare G+, J Neuroophthalmol 25(2), 109<br />
(2002): Balach<strong>and</strong>ran C+, Clin Experiment Ophthalmol 30(6), 440<br />
Scotoma<br />
(2006): Sbeity ZH+, JMedLiban54(3), 164<br />
Visual disturbances<br />
(2004): Johansson B, Acta Ophthalmol Sc<strong>and</strong> 2004 Oct;82(5), 625<br />
Other<br />
Anaphylactoid reactions/Anaphylaxis (1–10%)<br />
(2006): Houtman PM+, J Clin Rheumatol 12(6), 321 (with<br />
etanercept)<br />
METHOTREXATE 357<br />
(2003): Prescrire Int 12(64), 59<br />
(2003): MacGinnitie AJ+, Pediatr Allergy Immunol 14(5), 409<br />
(1996): Alkins SA+, Cancer 77, 2123<br />
(1995): Lobelle C+, Pediatr Hematol Oncol 12, 213<br />
C<strong>and</strong>idiasis<br />
Cough<br />
(2006): Weisman MH+, Arthritis Rheum 54(2), 607<br />
Death<br />
(2006): Kelly H+, Obstet Gynecol 107(2), 439<br />
(2005): Kinder AJ+, Rheumatology (Oxford) 44(1), 61<br />
Gynecomastia<br />
(2006): P<strong>and</strong>hi D+, Clin Exp Dermatol 31(1), 138<br />
(2004): Schmutz JL+, Ann Dermatol Venereol 131(11), 1024<br />
(1995): Finger DR+, J Rheumatol 22, 796<br />
(1995): Thomas E+, J Rheumatol 22, 2189<br />
(1983): Del Paine DW+, Arthritis Rheum 26, 691<br />
Hepatotoxicity<br />
(2006): Berends MA+, Aliment Pharmacol Ther 24(5), 805<br />
(2006): Boey O+, Acta Clin Belg 61(4), 166<br />
(2006): Tilling L+, Clin <strong>Drug</strong> Investig 26(2), 55<br />
(2005): Nieminen U+, Duodecim - Duodecim 121(24), 2680<br />
(2005): Tonanont M+, J Med Assoc Thai 88(10), 1349 (6%)<br />
(1998): Hakim NS+, Int Surg 83(3), 224<br />
(1997): Cuellar ML+, Rheum Dis Clin North Am 23(4), 797<br />
Hypersensitivity<br />
(2003): Prescrire Int 12(64), 59<br />
Inappropriate secretion of antidiuretic hormone (SIADH)<br />
(1988): Frahm H+, Z Gesamte Inn Med 43(15), 411<br />
Myalgia/Myositis/Myopathy/Myotoxicity<br />
Nephrotoxicity<br />
(2006): Widemann BC+, Oncologist 11(6), 694<br />
(2004): Widemann BC+, Cancer 100(10), 2222 (%)<br />
(2003): Kinoshita A+, Cancer Chemother Pharmacol 51(3), 256<br />
(2003): Miyazaki J+, Nippon Rinsho 61(6), 973<br />
(2002): Sal<strong>and</strong> JM+, Pediatr Nephrol 17(10), 825<br />
(2002): Sauer M+, Pediatr Hematol Oncol 19(2), 135<br />
(2001): Kintzel PE, <strong>Drug</strong> Saf 24(1), 19<br />
(2000): Abrey LE+, J Clin Oncol 18(17), 3144<br />
(1999): Krackhardt A+, Leuk Lymphoma 35(5–6), 631<br />
(1998): Kepka L+, Leuk Lymphoma 29(1–2), 205<br />
(1998): Koch Nogueira PC+, Pediatr Nephrol 12(7), 572<br />
(1997): Tesar V+, Cas Lek Cesk 136(7), 205<br />
(1997): Widemann BC+, J Clin Oncol 15(5), 2125<br />
Neurotoxicity<br />
(2006): Haykin ME+, J Neurooncol 76(2), 153<br />
(2006): Nakajima D+, No To Hattatsu 38(3), 195<br />
Panniculitis<br />
(2002): Nezondet-Chetaille AL+, Joint Bone Spine 69(3), 324<br />
Peyronie’s disease<br />
(1992): Phelan MJI, Br J Rheumatol 31, 425<br />
Porphyria cutanea tarda<br />
(1983): Malina L+, ZHautkr(German) 58, 241<br />
Pseudolymphoma<br />
(1997): Flipo RM+, J Rheumatol 24, 809<br />
(1995): Delaporte E+, Ann Dermatol Venereol (French) 122, 521<br />
(20 cases)<br />
(1994): Zimmer-Galler I+, Mayo Clin Proc 69, 258<br />
(1993): Kamel OW+, NEnglJMed328, 1317<br />
(1993): Kerl H+, Dermatology in General Medicine McGraw-Hill,<br />
New York<br />
(1993): Shiroky JB+, NEnglJMed329(22), 1657<br />
(1993): Taillan B+, Rev Rhum Ed Fr 60(3), 248<br />
(1992): Kingsmore SF+, J Rheumatol 19(9), 1462<br />
(1991): Ellman MH+, J Rheumatol 18(11), 1741<br />
(1991): Shiroky JB+, J Rheumatol 18(8), 1172<br />
Tendinopathy/Tendon rupture<br />
(2001): Toverud EL+, Med Pediatr Oncol 37(2), 156 (Achilles;<br />
repeated)
Change language